Telemetry Investments’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-45,000
| Closed | -$225K | – | 106 |
|
|
2018
Q1 | $225K | Sell |
45,000
-74,497
| -62% | -$372K | 0.08% | 86 |
|
|
2017
Q4 | $603K | Buy |
119,497
+9,497
| +9% | +$47.9K | 0.23% | 33 |
|
|
2017
Q3 | $682K | Sell |
110,000
-108,400
| -50% | -$672K | 0.24% | 37 |
|
|
2017
Q2 | $786K | Sell |
218,400
-6,600
| -3% | -$23.8K | 0.37% | 35 |
|
|
2017
Q1 | $731K | Buy |
225,000
+75,000
| +50% | +$244K | 0.33% | 33 |
|
|
2016
Q4 | $368K | Buy |
+150,000
| New | +$368K | 0.21% | 48 |
|
|
2016
Q1 | – | Sell |
-101,000
| Closed | -$449K | – | 93 |
|
|
2015
Q4 | $449K | Buy |
101,000
+38,640
| +62% | +$172K | 0.15% | 72 |
|
|
2015
Q3 | $380K | Buy |
62,360
+5,860
| +10% | +$35.7K | 0.16% | 82 |
|
|
2015
Q2 | $670K | Buy |
56,500
+8,500
| +18% | +$101K | 0.3% | 57 |
|
|
2015
Q1 | $838K | Buy |
48,000
+12,500
| +35% | +$218K | 0.46% | 37 |
|
|
2014
Q4 | $538K | Buy |
+35,500
| New | +$538K | 0.33% | 56 |
|